The influence of personality traits on the placebo/nocebo response
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE Some people might be more prone to placebo and nocebo responses than others depending on their personality traits. We aimed to provide a systematic review on the influence of personality traits on placebo and nocebo responses in controlled and uncontrolled studies. METHODS We conducted a systematic literature search in the databases CINAHL, AMED, PsycINFO and EMBASE for relevant publications published between January 1997 and March 2018. For all included papers, we conducted an additional forward search. RESULTS After screening 407 references, we identified 24 studies. The Big Five (i.e., neuroticism, extraversion, openness to experience, agreeableness and conscientiousness) and optimism were the most frequently investigated personality traits. Several studies found a positive association between optimism and the placebo response. Furthermore, we found that higher anxiety was associated with increased nocebo responses. CONCLUSION Evidence points to a possible association between optimism and the placebo response. Therefore, further emphasising the investigation of the influence of optimism on the placebo/nocebo response seems warranted. For clinical practice, the impact of anxiety on the nocebo response might be important to identify patients who might be more prone to experiencing side effects of medical treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900
Nonspecific medication side effects and the nocebo phenomenon
Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784 · cited 1×
“A nocebo describes the noxious effect of the placebo [2] meaning the placebo intervention produces adverse side effects [3].”
BackgroundPlacebo interventions for all clinical conditions
Hróbjartsson, A., & Gøtzsche, P. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003974.pub3 · Cited by 777
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671 · cited 1×
“Placebo and nocebo effects have been subjects of research for decades, as they might impact clinical outcomes [5].”
BackgroundWhen words are painful: unraveling the mechanisms of the nocebo effect
Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.020 · Cited by 636 · cited 1×
“A nocebo describes the noxious effect of the placebo [2] meaning the placebo intervention produces adverse side effects [3].”
BackgroundPlacebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465
De Fruyt, F., Van De Wiele, L., & Van Heeringen, C. (2000) · Personality and Individual Differences · doi:10.1016/s0191-8869(99)00204-4 · Cited by 455
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect
Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419
The role of learning in nocebo and placebo effects
Colloca, L., Sigaudo, M., & Benedetti, F. (2008) · Pain · doi:10.1016/j.pain.2008.02.006 · Cited by 411 · cited 1×
“Genetics/biomarkers [10-12], learning and conditioning [6, 13, 14], individual”
Meta-analysis of the placebo response in antidepressant trials.
Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J., & Hofmann, S. G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.029 · Cited by 346 · cited 1×
“For antidepressant trials, it has been reported that the placebo effect accounts for up to 68% of the effect of the medication [7].”
Background
Research works printed but not linked: 45
- Häuser, 2012, Nocebo phenomena in medicine: their relevance in everyday clinical practice, Dtsch. Arztebl. Int., 109, 459
- Rutherford, 2013, A model of placebo response in antidepressant clinical trials, Am. J. Psychiatry, 170, 723, 10.1176/appi.ajp.2012.12040474 · DOI · Paper page
- Rief, 2008, The power of expectation–understanding the placebo and nocebo phenomenon, Soc. Personal. Psychol. Compass, 2, 1624, 10.1111/j.1751-9004.2008.00121.x · DOI · Paper page
- Peciña, 2014, FAAH selectively influences placebo effects, Mol. Psychiatry, 19, 385, 10.1038/mp.2013.124 · DOI
- Weimer, 2015, Placebo effects in psychiatry: mediators and moderators, Lancet Psychiatry, 2, 246, 10.1016/S2215-0366(14)00092-3 · DOI · Paper page
- Bartels, 2016, Placebo and nocebo effects on itch: effects, mechanisms, and predictors, Eur. J. Pain, 20, 8, 10.1002/ejp.750 · DOI
- Bialosky, 2010, Individual expectation: an overlooked, but pertinent, factor in the treatment of individuals experiencing musculoskeletal pain, Phys. Ther., 90, 1345, 10.2522/ptj.20090306 · DOI · Paper page
- Enck, 2008, New insights into the placebo and Nocebo responses, Neuron, 59, 195, 10.1016/j.neuron.2008.06.030 · DOI · Paper page
- Kaptchuk, 2008, Do “placebo responders” exist?, Contemp Clin Trials, 29, 587, 10.1016/j.cct.2008.02.002 · DOI
- Jakšić, 2013, Does personality play a relevant role in the placebo effect?, Psychiatr. Danub., 25, 0
- Horing, 2014, Prediction of placebo responses: a systematic review of the literature, Front. Psychol., 5, 1079, 10.3389/fpsyg.2014.01079 · DOI
- Darragh, 2015, Who responds to placebos? Considering the “placebo personality” via a transactional model, Psychol. Health Med., 20, 287, 10.1080/13548506.2014.936885 · DOI
- Khan, 2005, Magnitude of placebo response and drug–placebo differences across psychiatric disorders, Psychol. Med., 35, 743, 10.1017/S0033291704003873 · DOI
- Kirsch, 2002, The emperor’s new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration, Prev. Treat., 5, 23a
- Enck, 2009, Der Placeboeffekt in der Medizin, Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz, 52, 635, 10.1007/s00103-009-0849-x · DOI
- Laidlaw, 2005, Low self-directedness (TCI), mood, schizotypy and hypnotic susceptibility, Pers. Individ. Differ., 39, 469, 10.1016/j.paid.2005.01.025 · DOI
- Beedie, 2008, Identification of placebo responsive participants in 40km laboratory cycling performance, J. Sports Sci. Med., 7, 166
- Beissner, 2015, Placebo-induced somatic sensations: a multi-modal study of three different placebo interventions, PLoS One, 10, 10.1371/journal.pone.0124808 · DOI
- Darragh, 2014, Investigating the ‘placebo personality’ outside the pain paradigm, J. Psychosom. Res., 76, 414, 10.1016/j.jpsychores.2014.02.011 · DOI
- De Pascalis, 2017, The behavioural approach system and placebo analgesia during cold stimulation in women: a low-resolution brain electromagnetic tomography (LORETA) analysis of startle ERPs, Pers. Individ. Differ., 118, 56, 10.1016/j.paid.2017.03.003 · DOI
- Geers, 2007, Further evidence for individual differences in placebo responding: an interactionist perspective, J. Psychosom. Res., 62, 563, 10.1016/j.jpsychores.2006.12.005 · DOI
- Corsi, 2017, Placebo and Nocebo effects: the advantage of measuring expectations and psychological factors, Front. Psychol., 8, 308, 10.3389/fpsyg.2017.00308 · DOI · Paper page
- Geers, 2010, Dispositional optimism predicts placebo analgesia, J. Pain, 11, 1165, 10.1016/j.jpain.2010.02.014 · DOI · Paper page
- Hyland, 2007, Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy, J. Psychosom. Res., 62, 331, 10.1016/j.jpsychores.2006.10.006 · DOI
- Rosén, 2017, Effects of subtle cognitive manipulations on placebo analgesia – an implicit priming study, Eur. J. Pain, 21, 594, 10.1002/ejp.961 · DOI
- Yu, 2014, Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity, Hum. Brain Mapp., 35, 4583, 10.1002/hbm.22496 · DOI
- Sullivan, 2008, Catastrophizing and treatment outcome: differential impact on response to placebo and active treatment outcome, Contemp. Hypn., 25, 129, 10.1002/ch.365 · DOI
- Aslaksen, 2015, Fear of pain potentiates nocebo hyperalgesia, J. Pain Res., 8, 703, 10.2147/JPR.S91923 · DOI
- Szemerszky, 2010, Polluted places or polluted minds? An experimental sham-exposure study on background psychological factors of symptom formation in ’Idiophatic environmental intolerance attributed to electromagnetic fields, Int. J. Hyg. Environ. Health, 213, 387, 10.1016/j.ijheh.2010.05.001 · DOI
- Webster, 2018, Medicine-related beliefs predict attribution of symptoms to a sham medicine: a prospective study, Br. J. Health Psychol., 23, 436, 10.1111/bjhp.12298 · DOI
- Witthöft, 2013, Are media warnings about the adverse health effects of modern life self-fulfilling? an experimental study on idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF), J. Psychosom. Res., 74, 206, 10.1016/j.jpsychores.2012.12.002 · DOI · Paper page
- Corsi, 2017, Placebo and Nocebo effects: the advantage of measuring expectations and psychological factors, Front. Psychol., 8, 308, 10.3389/fpsyg.2017.00308 · DOI · Paper page
- Link, 2006, Placebo/nocebo symptom reporting in a sham herbal supplement trial, Eval Health Prof, 29, 394, 10.1177/0163278706293403 · DOI
- Staats, 2001, The additive impact of anxiety and a placebo on pain, Pain Med., 2, 267, 10.1046/j.1526-4637.2001.01046.x · DOI
- Van Laarhoven, 2011, Induction of nocebo and placebo effects on itch and pain by verbal suggestions, Pain, 152, 1486, 10.1016/j.pain.2011.01.043 · DOI · Paper page
- Nevelsteen, 2007, Effects of information and 50 Hz magnetic fields on cognitive performance and reported symptoms, Bioelectromagnetics, 28, 53, 10.1002/bem.20265 · DOI
- Put, 2004, Negative affectivity and the influence of suggestion on asthma symptoms, J. Psychosom. Res., 57, 249, 10.1016/S0022-3999(03)00541-5 · DOI
- Howick, 2018, Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials, Trials, 19, 674, 10.1186/s13063-018-3042-4 · DOI
- Scheier, 1987, Dispositional optimism and physical well-being: the influence of generalized outcome expectancies on health, J. Pers., 55, 169, 10.1111/j.1467-6494.1987.tb00434.x · DOI · Paper page
- Abhishek, 2013, Mechanisms of the placebo response in pain in osteoarthritis, Osteoarthr. Cartil., 21, 1229, 10.1016/j.joca.2013.04.018 · DOI
- Planès, 2016, The nocebo effect of drugs, Pharmacol. Res. Perspect., 4, 10.1002/prp2.208 · DOI · Paper page
- Crichton, 2014, The link between health complaints and wind turbines: support for the nocebo expectations hypothesis, Front. Public Health, 2, 220, 10.3389/fpubh.2014.00220 · DOI
- Kelley, 2012, Open-label placebo for major depressive disorder: a pilot randomized controlled trial, Psychother. Psychosom., 81, 10.1159/000337053 · DOI · Paper page
- Carvalho, 2016, Open-label placebo treatment in chronic low back pain: a randomized controlled trial, Pain, 157, 2766, 10.1097/j.pain.0000000000000700 · DOI · Paper page
- Locher, 2019, Open-label placebo response – does optimism matter? a secondary-analysis of a randomized controlled trial, J. Psychosom. Res., 116, 25, 10.1016/j.jpsychores.2018.11.009 · DOI
Cited by
Pagni, B. A., Zeifman, R. J., Mennenga, S. E., Carrithers, B. M., Goldway, N., Bhatt, S., O’Donnell, K. C., Ross, S., & Bogenschutz, M. P. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230887 · Cited by 31
Tsigkaropoulou, E., Michopoulos, I., Porichi, E., Dafnas, K., Serretti, A., & Ferentinos, P. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000483 · Cited by 15
Mindfulness Effects on Anxiety: Disentangling the Role of Decentering and Treatment Expectations
Bos, D. P. A., Keesman, M., Roggeveen, A., Vase, L., Evers, A. W. M., & Peerdeman, K. J. (2024) · Behavior Therapy · doi:10.1016/j.beth.2024.03.004 · Cited by 5
Karacaoglu, M., Peerdeman, K. J., Karch, J. D., van Middendorp, H., & Evers, A. W. M. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111676
Metadata
- Authors
- Kern, A., Kramm, C., Witt, C. M., & Barth, J.
- Venue
- Journal of Psychosomatic Research
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 128
- Pages
- 109866
- ISSN
- 0022-3999 (ISSN-L)
- OpenAlex
- W2986989334
- Cited by
- 117
- References
- 17
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (105319_159833)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The influence of personality traits on the placebo/nocebo response. https://app.cochat.ai/papers/10.1016/j.jpsychores.2019.109866
- The paper
- Kern, A., Kramm, C., Witt, C. M., & Barth, J. (2020). The influence of personality traits on the placebo/nocebo response. Journal of Psychosomatic Research. https://doi.org/10.1016/j.jpsychores.2019.109866
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.